Amsacrine

安吖啶

Report date: 2023/02/08 16:14:37
NME

Base Information

Drug NameAmsacrine
Drug Alias NameamsacrineamsacrinumamsacrinaAmsidylAmsidine +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsLymphomaLeukemia
Global Approved IndicationsLymphomaLeukemia
Approved Indications in ChinaLymphomaLeukemia
Original Approved Country/TerritoryCanada
Original Approved Date1983/12/31
Country/TerritoryCanadaSwedenUnited Kingdom +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLymphomaLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeL01XX01